CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Biontech against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINEJul 22, 2025
Nucleic Acid VaccinesMODERNATXJul 9, 2025
Nucleic Acid VaccinesMODERNATXJul 9, 2025
High-Purity Peg Lipids And Uses ThereofMODERNATXJul 2, 2025
Methods Of Preparing Lipid NanoparticlesMODERNATXFeb 6, 2025
Method For Producing Rna CompositionsCUREVACOct 4, 2024
Method Of Increasing The Replication Of A Circular Dna MoleculeCUREVAC MANUFACTURINGSep 25, 2024
Neoantigen Identification, Manufacture, And UseGRITSTONE BIOAug 8, 2024
Modified Messenger Rna Comprising Functional Rna ElementsMODERNATXFeb 23, 2024
Artificial Nucleic Acid Molecules For Improved Protein ExpressionCUREVACDec 6, 2023

Explore Biontech's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jul 26, 2023Enhancing The Effect Of Car-Engineered T Cells By Means Of Nucleic Acid Vaccination1
Apr 26, 2023Individualized Vaccines For Cancer1
Feb 16, 2022Claudin-6-Specific Immunoreceptors And T Cell Epitopes1
Oct 27, 2021Methods For Providing Single-Stranded Rna1
Sep 8, 2021Individualized Vaccines For Cancer1
Sep 2, 2020Claudin-18.2-Specific Immunoreceptors And T Cell Epitopes1
Jul 10, 2019Individualized Vaccines For Cancer3
Aug 8, 2018Methods And Kits For The Molecular Subtyping Of Tumors1

Top competitors of Biontech

Top competitors of Biontech based on patent oppositions.